又一重要组织成立,开辟心脏康复工作的新航路!

2018-05-31 佚名 医学界心血管频道

心脏康复,从“心”开始,关爱心血管疾病患者。

2018年5月28日,中国健康促进基金会在北京召开心脏康复发展专项基金管理委员会成立大会,正式宣布心脏康复发展专项基金管理委员会成立。

此次会议由中国健康促进基金会公益事业部王志琳副主任主持。中国健康促进基金会白书忠终身荣誉理事长、中国健康促进基金会公益事业部田京发主任、中山大学附属第一医院心血管内科药物临床中心黄慧玲副主任、上海绿谷制药有限公司刘红樱总监、北京美林科技有限责任公司刘金印总经理等受邀参加会议


会议现场

宣读基金管理委员会成立的决定并选举管理委员会成员

中国健康促进基金会陈刚副秘书长宣读关于设立中国健康促进基金会“心脏康复发展专项基金并成立第一届管理委员会的决定”,宣读推荐的管理委员会委员名单,拟选举产生专项基金管理委员会主任委员、副主任委员、秘书长和副秘书长等。

经过民主选举,会议决定聘请中国健康促进基金会白书忠终身荣誉理事长担任该专项基金管理委员会名誉主任委员,选举田京发担任主任委员, 黄慧玲、刘红樱、刘金印为副主任委员,黄冬梅为秘书长,郭常松为常务副秘书长,会议还选举产生了吴非和任政杰等5位委员。




颁发聘书

白书忠理事长:为心血管疾病防治与康复事业做出积极贡献

白书忠理事长首先代表中国健康促进基金会向新成立的心脏康复发展专项基金管理委员会表示热烈地祝贺,向热情支持和积极参与心脏康复发展专项基金的各位专家和同仁、以及媒体界的朋友们致以诚挚的谢意!


白书忠理事长

白书忠理事长表示,《中国心血管疾病报告2017》中已指出,我国居民心血管疾病死亡率居各种疾病之首,全国有心血管疾病患者2.9亿,每5个成人中就有1人患心血管疾病。在现代医疗理念中,以疾病的诊断和治疗为核心,而对于疾病预防和病后康复管理却关注甚少。如何实现从疾病的发现、诊断、治疗,到后期的康复全流程的管理,是迫切需要解决的现实问题,也是患者热切期待解决的重大问题。

中共十九大报告要求为国民提供全方位、全周期的健康服务;患者出院后,要在基层医疗机构实施康复工作,使患者最大限度地恢复器官功能,促使其回归社会,提升生命质量。为实现这一目标,一方面需加强临床研究,为心血管疾病康复工作提供循证医学证据,另一方面为基层医疗机构赋能,提供知识、技术、工具、管理手段。心脏康复发展专项基金的成立,正是应对了这一需求。白书忠理事长向管理委员会提出了殷切希望,望管理委员会遵守专项基金的宗旨和业务范围,谋划并实施好各项工作,为心血管疾病防治与康复事业做出积极贡献。

田京发主任委员:重视心血管疾病康复,关爱患者健康

田京发主任表示,近些年来心血管疾病的发病率一路飚升,患病人数之多出乎了很多医生和健康专家的预测。为了使心血管疾病康复得到更广泛的推进,培训帮扶医生以及救助贫困心血管疾病患者,基金会决定成立心脏康复发展专项基金,旨在呼吁社会重视心血管疾病康复,关爱患者健康。


田京发主任

专项基金管理委员会成立后,将努力做好以下四方面的工作:

一是搭平台。搭平台是指通过专项基金这个平台,吸纳更多的社会资金、善款,推动基金工作的持续进行,同时通过专家团队的支持,使我们的工作能够更加有效,能够吸引更多的社会关注;

二是建体系。上级医院,特别是三甲医院在做了心脏功能等评估之后,如何将患者接管到基层医院,使心脏康复工作有序的推进下去,这需要建立一个科学的组织体系。这项组织体系的建设也是我们工作的一项重点;

三是建机制。组织体系建立起来后,如何能够有效地推动它,让体系的每一个层级都高效、积极地运转,这就需要有一个推动机制。这也是我们将认真研究的工作。

最后一个是守规则。在管理委员会工作实施过程中,将严格执行基金会的规章、制度,尤其是财务制度,使每一分善款都用到实处。

专项基金成立后,将依法开展资金募集活动,接受社会各界捐赠和赞助,推动心血管疾病康复技术在医疗机构的规范化应用;专项基金将积极支持心血管疾病相关的科研项目,支持开展心血管领域的人才培养、学术交流与合作,支持在健康管理示范基地开展多中心应用研究;专项基金将奖励在心血管疾病预防诊疗与康复相关工作中做出突出贡献的单位、团体及个人,救助心血管疾病贫困患者等等。心脏康复发展专项基金的建设与发展将为提高人民群众的健康水平,推动心血管疾病康复的医疗事业做出积极贡献!

专项基金管理委员会举行第一次工作会议

心脏康复发展专项基金管理委员会举行第一次工作会议。会议讨论并通过了中国健康促进基金会心脏康复发展专项基金管理委员会管理办法、工作计划等事宜。最后,与会专家、领导集体合影留念,大会圆满闭幕。


全体合影

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=320169, encodeId=5279320169fc, content=阅, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/fhZdOu27e88Voqh19n8eF8cLplo8L4nicKtH0WnE3KFELXns5XDu8rsiceK2HHDZc2SEStia5VV3Pia2QLMVqlWbHw/0, createdBy=6e012139475, createdName=神功盖世, createdTime=Thu May 31 06:57:26 CST 2018, time=2018-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=320147, encodeId=210f32014e2e, content=了解了解.继续关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Thu May 31 06:14:39 CST 2018, time=2018-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=320139, encodeId=ae7d320139c3, content=学习.谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyhb9xDeHojCicsdRdyC3XXdGk2ib9yLypZuHN06WeW4HO8WN0GGrgEfvnTX8gsckof05GHOU5OM4Mvx/0, createdBy=9cee1982656, createdName=执着追梦, createdTime=Thu May 31 05:55:39 CST 2018, time=2018-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=320128, encodeId=585f32012897, content=学习谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib2JlGvwpAibiaovVhfA9DbO7X7JLGGjM4Cic6oMgxLdnuS9piaP9cnG2OwIbkzHvX0qzS1boibyYNqR5vHZu7HQs5EIB/0, createdBy=298d1398341, createdName=lou.minghong, createdTime=Thu May 31 05:44:53 CST 2018, time=2018-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=320126, encodeId=76e03201268e, content=好好好好好好好好, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/29/bbc5cc0eed9b8d17623d2fd49dbdf19a.jpg, createdBy=79522135794, createdName=yjs木玉, createdTime=Thu May 31 05:27:02 CST 2018, time=2018-05-31, status=1, ipAttribution=)]
    2018-05-31 神功盖世

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=320169, encodeId=5279320169fc, content=阅, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/fhZdOu27e88Voqh19n8eF8cLplo8L4nicKtH0WnE3KFELXns5XDu8rsiceK2HHDZc2SEStia5VV3Pia2QLMVqlWbHw/0, createdBy=6e012139475, createdName=神功盖世, createdTime=Thu May 31 06:57:26 CST 2018, time=2018-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=320147, encodeId=210f32014e2e, content=了解了解.继续关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Thu May 31 06:14:39 CST 2018, time=2018-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=320139, encodeId=ae7d320139c3, content=学习.谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyhb9xDeHojCicsdRdyC3XXdGk2ib9yLypZuHN06WeW4HO8WN0GGrgEfvnTX8gsckof05GHOU5OM4Mvx/0, createdBy=9cee1982656, createdName=执着追梦, createdTime=Thu May 31 05:55:39 CST 2018, time=2018-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=320128, encodeId=585f32012897, content=学习谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib2JlGvwpAibiaovVhfA9DbO7X7JLGGjM4Cic6oMgxLdnuS9piaP9cnG2OwIbkzHvX0qzS1boibyYNqR5vHZu7HQs5EIB/0, createdBy=298d1398341, createdName=lou.minghong, createdTime=Thu May 31 05:44:53 CST 2018, time=2018-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=320126, encodeId=76e03201268e, content=好好好好好好好好, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/29/bbc5cc0eed9b8d17623d2fd49dbdf19a.jpg, createdBy=79522135794, createdName=yjs木玉, createdTime=Thu May 31 05:27:02 CST 2018, time=2018-05-31, status=1, ipAttribution=)]
    2018-05-31 1dd8c52fm63(暂无匿称)

    了解了解.继续关注

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=320169, encodeId=5279320169fc, content=阅, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/fhZdOu27e88Voqh19n8eF8cLplo8L4nicKtH0WnE3KFELXns5XDu8rsiceK2HHDZc2SEStia5VV3Pia2QLMVqlWbHw/0, createdBy=6e012139475, createdName=神功盖世, createdTime=Thu May 31 06:57:26 CST 2018, time=2018-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=320147, encodeId=210f32014e2e, content=了解了解.继续关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Thu May 31 06:14:39 CST 2018, time=2018-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=320139, encodeId=ae7d320139c3, content=学习.谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyhb9xDeHojCicsdRdyC3XXdGk2ib9yLypZuHN06WeW4HO8WN0GGrgEfvnTX8gsckof05GHOU5OM4Mvx/0, createdBy=9cee1982656, createdName=执着追梦, createdTime=Thu May 31 05:55:39 CST 2018, time=2018-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=320128, encodeId=585f32012897, content=学习谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib2JlGvwpAibiaovVhfA9DbO7X7JLGGjM4Cic6oMgxLdnuS9piaP9cnG2OwIbkzHvX0qzS1boibyYNqR5vHZu7HQs5EIB/0, createdBy=298d1398341, createdName=lou.minghong, createdTime=Thu May 31 05:44:53 CST 2018, time=2018-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=320126, encodeId=76e03201268e, content=好好好好好好好好, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/29/bbc5cc0eed9b8d17623d2fd49dbdf19a.jpg, createdBy=79522135794, createdName=yjs木玉, createdTime=Thu May 31 05:27:02 CST 2018, time=2018-05-31, status=1, ipAttribution=)]
    2018-05-31 执着追梦

    学习.谢谢分享

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=320169, encodeId=5279320169fc, content=阅, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/fhZdOu27e88Voqh19n8eF8cLplo8L4nicKtH0WnE3KFELXns5XDu8rsiceK2HHDZc2SEStia5VV3Pia2QLMVqlWbHw/0, createdBy=6e012139475, createdName=神功盖世, createdTime=Thu May 31 06:57:26 CST 2018, time=2018-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=320147, encodeId=210f32014e2e, content=了解了解.继续关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Thu May 31 06:14:39 CST 2018, time=2018-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=320139, encodeId=ae7d320139c3, content=学习.谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyhb9xDeHojCicsdRdyC3XXdGk2ib9yLypZuHN06WeW4HO8WN0GGrgEfvnTX8gsckof05GHOU5OM4Mvx/0, createdBy=9cee1982656, createdName=执着追梦, createdTime=Thu May 31 05:55:39 CST 2018, time=2018-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=320128, encodeId=585f32012897, content=学习谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib2JlGvwpAibiaovVhfA9DbO7X7JLGGjM4Cic6oMgxLdnuS9piaP9cnG2OwIbkzHvX0qzS1boibyYNqR5vHZu7HQs5EIB/0, createdBy=298d1398341, createdName=lou.minghong, createdTime=Thu May 31 05:44:53 CST 2018, time=2018-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=320126, encodeId=76e03201268e, content=好好好好好好好好, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/29/bbc5cc0eed9b8d17623d2fd49dbdf19a.jpg, createdBy=79522135794, createdName=yjs木玉, createdTime=Thu May 31 05:27:02 CST 2018, time=2018-05-31, status=1, ipAttribution=)]
    2018-05-31 lou.minghong

    学习谢谢分享!

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=320169, encodeId=5279320169fc, content=阅, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/fhZdOu27e88Voqh19n8eF8cLplo8L4nicKtH0WnE3KFELXns5XDu8rsiceK2HHDZc2SEStia5VV3Pia2QLMVqlWbHw/0, createdBy=6e012139475, createdName=神功盖世, createdTime=Thu May 31 06:57:26 CST 2018, time=2018-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=320147, encodeId=210f32014e2e, content=了解了解.继续关注, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Thu May 31 06:14:39 CST 2018, time=2018-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=320139, encodeId=ae7d320139c3, content=学习.谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyhb9xDeHojCicsdRdyC3XXdGk2ib9yLypZuHN06WeW4HO8WN0GGrgEfvnTX8gsckof05GHOU5OM4Mvx/0, createdBy=9cee1982656, createdName=执着追梦, createdTime=Thu May 31 05:55:39 CST 2018, time=2018-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=320128, encodeId=585f32012897, content=学习谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib2JlGvwpAibiaovVhfA9DbO7X7JLGGjM4Cic6oMgxLdnuS9piaP9cnG2OwIbkzHvX0qzS1boibyYNqR5vHZu7HQs5EIB/0, createdBy=298d1398341, createdName=lou.minghong, createdTime=Thu May 31 05:44:53 CST 2018, time=2018-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=320126, encodeId=76e03201268e, content=好好好好好好好好, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/29/bbc5cc0eed9b8d17623d2fd49dbdf19a.jpg, createdBy=79522135794, createdName=yjs木玉, createdTime=Thu May 31 05:27:02 CST 2018, time=2018-05-31, status=1, ipAttribution=)]
    2018-05-31 yjs木玉

    好好好好好好好好

    0